Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 6—June 2020
Research Letter

Sabiá Virus–Like Mammarenavirus in Patient with Fatal Hemorrhagic Fever, Brazil, 2020

Figures
Article Metrics
Fernanda de Mello Malta1, Deyvid Amgarten1, Ana Catharina de Seixas Santos Nastri, Yeh-Li Ho, Luciana Vilas Boas Casadio, Marcela Basqueira, Gloria Selegatto, Murilo Castro Cervato, Amaro Nunes Duarte-Neto, Hermes Ryoiti Higashino, Felipe Arthur Faustino Medeiros, José Luiz Pinto Lima Gendler, Anna S. Levin, and João Renato Rebello PinhoComments to Author 
Author affiliations: Hospital Israelita Albert Einstein, São Paulo, Brazil (F.M. Malta, D. Amgarten, M. Basqueira, M.C. Cervato, J.R.R. Pinho); Universidade de São Paulo, São Paulo (D. Amgarten, A.C. de Seixas Santos Nastri, Y.-L. Ho, L.V.R. Casadio, G. Selegatto, A.N. Duarte-Neto, H.R. Higashino, F.A.F. Medeiros, J.L.P.L. Gendler, A.S. Levin, J.R.R. Pinho)

Cite This Article

Abstract

New World arenaviruses can cause chronic infection in rodents and hemorrhagic fever in humans. We identified a Sabiá virus–like mammarenavirus in a patient with fatal hemorrhagic fever from São Paulo, Brazil. The virus was detected through virome enrichment and metagenomic next-generation sequencing technology.

Viral infections have become an important public health issue in South America during the past 2 decades. Outbreaks of arboviral disease, such as dengue, chikungunya, Zika, and yellow fever, have increased concern about improving surveillance and diagnosis of viral infections in anticipation of the next threat (14). South American arenaviruses belong to the New World serogroups, cause chronic infection in rodents, and have been associated with neurologic symptoms and hemorrhagic fever in humans (5).

We report a fatal case of a new Sabiá virus (SABV)–like mammarenavirus infection in São Paulo, Brazil, in a previously healthy 52-year-old man. On December 30, 2019, he sought care at a basic health facility for odynophagia, epigastric pain radiating to the chest, nausea, vertigo, xerostomy, and myalgia. During the next few days, his signs and symptoms worsened to intense myalgia, fever, drowsiness, and hypotension, so he was referred to the Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo (São Paulo, Brazil), on January 6, 2020. At admission, he had bilateral conjunctivitis, diffuse skin rash, cervical lymphadenopathy, and altered mental status.

Blood samples were sent to the Laboratorio de Tecnicas Especiais (LATE), Hospital Israelita Albert Einstein (São Paulo, Brazil). Results of serologic and molecular tests were negative for yellow fever, dengue, Zika, and chikungunya viruses; viral hepatitis; enteroviruses; and herpesviruses. Further testing was performed with a newly implemented routine test for RNA viruses, a virome enrichment technique, and metagenomic next-generation sequencing (NGS) technology. In brief, total RNA was extracted from plasma, and human rRNA was depleted. Reverse transcription of RNA was performed with a 2-step cDNA random synthesis, followed by PCR amplification, adapted from Greninger et al. (6). We then generated DNA libraries using Illumina Nextera XT (Illumina, https://www.illumina.com) and sequenced them using Illumina NextSeq 550. We used the data generated as input for an in-house bioinformatics pipeline, performed as follows: raw data quality control, human decontamination, first round of pathogen identification, reads assembly, second round of identification with contigs, and finding confirmation through mapping and calculating quality metrics.

The patient’s condition deteriorated, and he died on January 11. Main autopsy findings were cerebral edema, hepatomegaly with steatotic aspect, and pulmonary hemorrhage. Microscopy showed panlobular hepatitis, with steatotic and apoptotic hepatocytes, hyperplasic Kupffer cells, and mild inflammatory reaction in the liver. Ischemic coagulative necrosis around central vein was also noted. Other findings included bronchopneumonia, acute tubular necrosis, and hemophagocytosis in the bone marrow. Detailed histologic studies are under way.

Figure

Thumbnail of Genomic and phylogenetic analysis of SABV-like mammarenavirus (SP2019-01) from a patient with fatal hemorrhagic fever, Brazil, 2020. A) Genome plots comparing strain SP2019-01 with SABV strain SPH114202, showing identity throughout the genome and variant sites (black lines). B) Maximum-likelihood tree of SP2019-01 (red box) based on the alignment of arenavirus sequences. Tree was rooted in the Haartman Institute virus isolate sequence, and bootstrap values are shown next to the bran

Figure. Genomic and phylogenetic analysis of SABV-like mammarenavirus (SP2019-01) from a patient with fatal hemorrhagic fever, Brazil, 2020. A) Genome plots comparing strain SP2019-01 with SABV strain SPH114202, showing identity throughout the...

The report of the virome test from the patient’s plasma sample identified the presence of a mammarenavirus, SP2019-01. Further bioinformatics analysis enabled recovery of 2 complete fragments of the viral genome corresponding to the small (S [3,308 bp]) and large (L [7,056 bp]) segments of an arenavirus; NGS average coverage was 117× for the S and 1,146× for the L segment. The S segment had 87% identity and the L segment had 89% identity in a full nucleotide alignment with SABV strain SPH114202 (Figure, panel A). We submitted sequences to GenBank (accession nos. MN956773 [L segment] and MN956774 [S segment]). A maximum-likelihood tree of the species within the Arenaviridae family shows strain SP2019-01 as a SABV-like mammarenavirus based on the alignment of arenavirus complete nucleotide sequences of the L segment (Figure, panel B).

SABV is a New World arenavirus that was previously isolated in São Paulo in 1994 in a patient with fatal hemorrhagic fever (7). Four additional New World arenavirus are known to be associated with human disease in South America: Junin, Machupo, Guanarito, and Chapare (8). Chapare virus is closely related to SABV and has been recently implicated in an outbreak of 5 cases (3 fatal) of hemorrhagic fever in Bolivia (8,9).

Little is known about the natural history of SABV infection. The wild reservoir species for this virus is still unknown but is probably a rodent (10). Three additional SABV cases in humans have been reported since 1994 including 2 in laboratory workers handling SABV samples, raising concern about the potential for aerosol transmission (10).

After the virome test report from this investigation was issued, the laboratory team took all measures to remove biological samples from laboratory routine testing and store them at −80°C. Persons who had any contact with the patient were informed and monitored and did not develop symptoms. Brazil health and surveillance authorities, as well as the US Centers for Disease Control and Prevention, were also informed. Our finding of an SABV-like arenavirus strain causing a fatal human infection in a region with a recent outbreak of yellow fever show the potential role of virome enrichment technique and metagenomic NGS for the etiologic diagnosis and identification of new pathogens in patients with hemorrhagic fever.

Dr. Malta is a senior laboratory analyst at the Laboratorio de Tecnicas Especiais, Hospital Israelita Albert Einstein, São Paulo. Her primary research interests include molecular characterization of virus genome (hepatitis C virus, hepatitis B virus, and yellow fever virus) DNA sequencing techniques.

Top

Acknowledgment

We thank HCFMUSP Infectious Diseases Department healthcare workers for their dedication to assisting patients, Venancio Alves for continuous support, and Cristóvão Luis Pitangueira Mangueira and Rubia Anita Ferraz Santana and the technical staff of Laboratorio de Tecnicas Especiais, Hospital Israelita Albert Einstein, for scientific and technical support.

Top

References

  1. Morens  DM, Fauci  AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog. 2013;9:e1003467. DOIPubMed
  2. Grubaugh  ND, Ladner  JT, Lemey  P, Pybus  OG, Rambaut  A, Holmes  EC, et al. Tracking virus outbreaks in the twenty-first century. Nat Microbiol. 2019;4:109. DOIPubMed
  3. Deng  X, Achari  A, Federman  S, Yu  G, Somasekar  S, Bártolo  I, et al. Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance. [Erratum in: Nat Microbiol. 2020;5:525.]. Nat Microbiol. 2020;5:44354. DOIPubMed
  4. Chong  HY, Leow  CY, Abdul Majeed  AB, Leow  CH. Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis. Virus Res. 2019;274:197770. DOIPubMed
  5. Brisse  ME, Ly  H. Hemorrhagic fever-causing arenaviruses: Lethal pathogens and potent immune suppressors. Front Immunol. 2019;10:372. DOIPubMed
  6. Greninger  AL, Naccache  SN, Federman  S, Yu  G, Mbala  P, Bres  V, et al. Rapid metagenomic identification of viral pathogens in clinical samples by real-time nanopore sequencing analysis. Genome Med. 2015;7:99. DOIPubMed
  7. Lisieux  T, Coimbra  M, Nassar  ES, Burattini  MN, de Souza  LT, Ferreira  I, et al. New arenavirus isolated in Brazil. Lancet. 1994;343:3912. DOIPubMed
  8. Delgado  S, Erickson  BR, Agudo  R, Blair  PJ, Vallejo  E, Albariño  CG, et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 2008;4:e1000047. DOIPubMed
  9. Escalera-Antezana  JP, Rodriguez-Villena  OJ, Arancibia-Alba  AW, Alvarado-Arnez  LE, Bonilla-Aldana  DK, Rodríguez-Morales  AJ. Clinical features of fatal cases of Chapare virus hemorrhagic fever originating from rural La Paz, Bolivia, 2019: A cluster analysis. Travel Med Infect Dis. 2020;101589; Epub ahead of print. DOIPubMed
  10. Ellwanger  JH, Chies  JAB. Keeping track of hidden dangers - The short history of the Sabiá virus. Rev Soc Bras Med Trop. 2017;50:38. DOIPubMed

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2606.200099

Original Publication Date: May 07, 2020

1These authors contributed equally to this article.

Table of Contents – Volume 26, Number 6—June 2020

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

João Renato Rebello Pinho, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Divisão de Laboratório Central, Biologia Molecular, Avenida Dr. Eneas de Carvalho Aguiar, 155, 2nd Fl, São Paulo, SP, Brazil

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: May 19, 2020
Page updated: May 19, 2020
Page reviewed: May 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external